Smith & Nephew Snats (SNN) 34.81 $SNN
Sports Medicine Companies Revenue Analysis 2016 - Arthrex, Arthrocare, Biomet DePuy Mitek, ConMed Linvatec, Smith & Nephew & Stryker - Research and Markets
BusinessWire - Thu Jul 07, 7:51AM CDT
Research and Markets has announced the addition of the "Sports Medicine Companies Revenue Analysis" report to their offering.
SNN: 34.81 (+0.52)
Research and Markets - Global Wound Dressings Market Value of USD 8.46 Billion by 2021 - Trends, Technologies & Opportunities Report 2016-2021 - Key Vendors: Smith & Nephew, Organogenesis, Medline Industries
PR Newswire - Mon Jun 27, 6:10AM CDT
Research and Markets has announced the addition of the "Wound Dressings Market by Type (Advanced Wound Dressings, Traditional Wound Dressings), Application (Surgical Wounds, Ulcers, Burns), End User (Inpatient Facilities, Outpatient Facilities) - Global Forecast to 2021" report to their offering.
SNN: 34.81 (+0.52)
After Yesterday's Rally of 1.15% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jun 22, 3:49PM CDT
Smith & Nephew (NYSE:SNN) traded in a range yesterday that spanned from a low of $34.19 to a high of $34.64. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $34.26 on volume of 228,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SNN: 34.81 (+0.52)
Australian Hyaluronic Acid Viscosupplementation Market Report 2016 Featuring Genzyme (Sanofi) & Bioventus (Smith & Nephew) - Research and Markets
BusinessWire - Mon Jun 20, 8:11AM CDT
Research and Markets has announced the addition of the "Australian Market Report for Hyaluronic Acid Viscosupplementation" report to their offering.
SNN: 34.81 (+0.52)
Global Sports Medicine Market 2016-2020 - Key Vendors are Arthrex, CONMED, DePuy Synthes, Smith & Nephew & Stryker
GlobeNewswire - Wed Jun 15, 8:19AM CDT
Research and Markets has announced the addition of the "Global Sports Medicine Market 2016-2020" report to their offering.
SNN: 34.81 (+0.52), CNMD: 49.60 (+0.27)
International companies to host live webcasts at Deutsche Bank's June 9th and 10th Depositary Receipts Virtual Investor Conference
PR Newswire Europe - Mon Jun 06, 8:01AM CDT
Deutsche Bank today announced the lineup for its June 9(th) and 10(th) Depositary Receipts Virtual Investor Conference ("dbVIC"
, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US.
SNN: 34.81 (+0.52), DL: 11.00 (-0.10), HCM: 12.99 (-0.36), DB: 14.10 (+0.80)
Orthopedic Surgeons from Around the World Travel to Colorado for the Vail International Knee Symposium (VICKS) June 9-11
PRWeb - Wed Jun 01, 7:07AM CDT
Robert LaPrade MD, PhD and Lars Engebretsen MD, PhD are teaming up with Smith & Nephew to host the 3rd Annual Vail International Knee Symposium (VICKS) in Vail, Colorado June 9 - 11, 2016. Throughout the course, attendees will gain hands-on experience with cadaveric training and hear case discussions from leading international experts on the latest techniques and technologies in knee arthroscopy.
SNN: 34.81 (+0.52)
Intelex Client Smith & Nephew Wins 2016 EH&S Information Management Award
PRWeb - Tue May 31, 9:12AM CDT
Smith & Nephew, a global medical technology business, was a recipient of the inaugural EH&S Information Management Award given out at the 2016 Verdantix Summit. One of only eight winners announced, Smith & Nephew won in the healthcare category for their development of an integrated safety and incident management system. Through its successful project for Smith & Nephew's Memphis location, Intelex Technologies, a global innovator of cloud-based environmental, health, safety, and quality (EHSQ) management software received a Verdantix EH&S Innovation Award.
SNN: 34.81 (+0.52)
Hip and Knee Orthopedic Surgical Implants - Global Market Outlook (2015-2022)
PR Newswire - Tue May 24, 4:32PM CDT
According to Stratistics MRC, the Global Hip and Knee Orthopedic Surgical Implants market is estimated at $18.26 billion in 2015 and is expected to grow at a CAGR of 9.54% to reach $34.57 billion by 2022. Technological advancements and rising geriatric population worldwide are some of the key factors fueling the market growth. On the other hand, abridged reimbursements by insurance companies are negatively affecting the market growth. Total hip replacement surgery is witnessing a significant rise driven by the technological advan. The aging US population is supporting the market demand, since the requirement of these medical devices is higher in the elderly population.
SNN: 34.81 (+0.52), JNJ: 122.92 (-0.01)
Medtronic to Expand Minimally Invasive Therapy Portfolio with Acquisition of Gynecology Business from Smith & Nephew
Globe Newswire - Wed May 18, 7:01AM CDT
DUBLIN - May 18, 2016 - Medtronic plc (NYSE: MDT) today announced it has signed a definitive agreement to acquire Smith & Nephew's (NYSE: SNN; LSE: SN) gynecology (GYN) business for approximately $350 million. This agreement reinforces Medtronic's dedication to expanding the use of less invasive treatments and demonstrates a commitment to improving options for women with abnormal uterine bleeding (AUB). The addition of the GYN portfolio will expand and strengthen Medtronic's minimally invasive surgical offerings and will further complement its existing global GYN business. The acquisition is expected to close this summer.
SNN: 34.81 (+0.52), MDT: 88.92 (+0.41)
Global Orthopaedic Device Company Profiles of The Top 5 - DePuy Synthes, Medtronic, Smith & Nephew, Stryker & Zimmer Biomet - Research and Markets
BusinessWire - Wed May 18, 6:50AM CDT
Research and Markets has announced the addition of the "Orthopaedic Device Company Profiles: The Top 5" company profile to their offering.
SNN: 34.81 (+0.52), MDT: 88.92 (+0.41)
Upgrade Alert for Smith & Nephew (SNN)
Comtex SmarTrend(R) - Tue May 10, 4:09AM CDT
Smith & Nephew (NYSE:SNN) was upgraded from Hold to Buy at Jefferies today. The stock closed yesterday at $34.04 on volume of 371,000 shares, above average daily volume of 302,000. There is potential upside of 17.1% for shares of Smith & Nephew based on a current price of $34.04 and an average consensus analyst price target of $39.88. The stock should hit resistance at its 200-day moving average (MA) of $34.17, as well as support at its 50-day MA of $33.33.
SNN: 34.81 (+0.52)
Laparoscopic Devices Market: Global Industry Analysis 2015-2025 - Key Players are Medtronic, Ethicon US LLC & Smith & Nephew - Research and Markets
BusinessWire - Mon Apr 18, 7:52AM CDT
Research and Markets has announced the addition of the "Laparoscopic Devices Market: Global Industry Analysis and Opportunity Assessment 2015-2025" report to their offering.
SNN: 34.81 (+0.52)
Smith & Nephew awarded Skin Integrity: Prevention, Healing and Support category agreement with Premier, Inc.
PR Newswire - Tue Apr 12, 7:00AM CDT
Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced that it has been awarded a group purchasing agreement for the Skin Integrity: Prevention, Healing and Support category with Premier, Inc. Effective April 1, 2016, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Smith & Nephew's Advanced Wound Care products, including the ALLEVYN(TM) family of hydrocellular foam dressings, SECURA(TM) skin care system and ACTICOAT(TM) silver-coated antimicrobial barrier dressings.
SNN: 34.81 (+0.52)
Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic and Smith & Nephew
Zacks Equity Research - Zacks Investment Research - Tue Mar 22, 8:30AM CDT
Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic and Smith & Nephew
SNN: 34.81 (+0.52), JNJ: 122.92 (-0.01), MDT: 88.92 (+0.41)
Medical Products Companies Tap Into $50 Billion U.S. Government GSA Supply Program
ACCESSWIRE - Wed Mar 16, 7:30AM CDT
REDONDO BEACH, CA / ACCESSWIRE / March 16, 2016 / Last week, BioLargo, Inc. (OTC: BLGO), best known for the AOS Filter that has demonstrated the highest impact and lowest cost of any known water treatment technology, announced that the U.S. government had awarded them a five-year General Services Administration and VA Schedule supply contract, under schedule 65IIA for medical equipment and supplies. This contract award is significant because it opens up an important selling channel for the company's current odor and moisture control products as well as future products that will include its Advanced Wound Care Products when they are approved by the FDA. The GSA Schedules program is the premier acquisition vehicle in government with approximately $50 Billion a year in spending for a broad spectrum of products.
DSCI: 4.13 (-0.06), SNN: 34.81 (+0.52), VCEL: 2.24 (-0.03), ALQA: 1.18 (-0.01)
New "see-and-treat" TRUCLEAR(TM) hysteroscope improves options for office hysteroscopy
PR Newswire - Wed Mar 09, 7:00AM CST
Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announced the launch of the TRUCLEAR 5C Hysteroscope Set for the combined diagnosis and removal of abnormalities within the uterine cavity. The ability to identify and remove intrauterine pathologies using a single scope is known as "see-and-treat" by surgeons and reduces the need for patients to schedule multiple visits.
SNN: 34.81 (+0.52)
Wound Closure & Advanced Wound Care Global Market Report 2016-2021 - Analysis, Trends, Technologies & Opportunities - Key Vendors: Integra Lifesciences Corp, Johnson & Johnson, Smith & Nephew
PR Newswire Europe - Tue Mar 08, 9:11AM CST
DUBLIN, March 8, 2016 /PRNewswire/ --
SNN: 34.81 (+0.52), JNJ: 122.92 (-0.01)
Sports Medicine Companies Revenue Analysis 2016 - Arthrex, Arthrocare, Biomet DePuy Mitek, ConMed Linvatec, Smith & Nephew & Stryker - Research and Markets
BusinessWire - Thu Jul 07, 7:51AM CDT
Research and Markets has announced the addition of the "Sports Medicine Companies Revenue Analysis" report to their offering.
SNN: 34.81 (+0.52)
Research and Markets - Global Wound Dressings Market Value of USD 8.46 Billion by 2021 - Trends, Technologies & Opportunities Report 2016-2021 - Key Vendors: Smith & Nephew, Organogenesis, Medline Industries
PR Newswire - Mon Jun 27, 6:10AM CDT
Research and Markets has announced the addition of the "Wound Dressings Market by Type (Advanced Wound Dressings, Traditional Wound Dressings), Application (Surgical Wounds, Ulcers, Burns), End User (Inpatient Facilities, Outpatient Facilities) - Global Forecast to 2021" report to their offering.
SNN: 34.81 (+0.52)
After Yesterday's Rally of 1.15% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jun 22, 3:49PM CDT
Smith & Nephew (NYSE:SNN) traded in a range yesterday that spanned from a low of $34.19 to a high of $34.64. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $34.26 on volume of 228,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SNN: 34.81 (+0.52)
Australian Hyaluronic Acid Viscosupplementation Market Report 2016 Featuring Genzyme (Sanofi) & Bioventus (Smith & Nephew) - Research and Markets
BusinessWire - Mon Jun 20, 8:11AM CDT
Research and Markets has announced the addition of the "Australian Market Report for Hyaluronic Acid Viscosupplementation" report to their offering.
SNN: 34.81 (+0.52)
Global Sports Medicine Market 2016-2020 - Key Vendors are Arthrex, CONMED, DePuy Synthes, Smith & Nephew & Stryker
GlobeNewswire - Wed Jun 15, 8:19AM CDT
Research and Markets has announced the addition of the "Global Sports Medicine Market 2016-2020" report to their offering.
SNN: 34.81 (+0.52), CNMD: 49.60 (+0.27)
International companies to host live webcasts at Deutsche Bank's June 9th and 10th Depositary Receipts Virtual Investor Conference
PR Newswire Europe - Mon Jun 06, 8:01AM CDT
Deutsche Bank today announced the lineup for its June 9(th) and 10(th) Depositary Receipts Virtual Investor Conference ("dbVIC"
, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US. SNN: 34.81 (+0.52), DL: 11.00 (-0.10), HCM: 12.99 (-0.36), DB: 14.10 (+0.80)
Orthopedic Surgeons from Around the World Travel to Colorado for the Vail International Knee Symposium (VICKS) June 9-11
PRWeb - Wed Jun 01, 7:07AM CDT
Robert LaPrade MD, PhD and Lars Engebretsen MD, PhD are teaming up with Smith & Nephew to host the 3rd Annual Vail International Knee Symposium (VICKS) in Vail, Colorado June 9 - 11, 2016. Throughout the course, attendees will gain hands-on experience with cadaveric training and hear case discussions from leading international experts on the latest techniques and technologies in knee arthroscopy.
SNN: 34.81 (+0.52)
Intelex Client Smith & Nephew Wins 2016 EH&S Information Management Award
PRWeb - Tue May 31, 9:12AM CDT
Smith & Nephew, a global medical technology business, was a recipient of the inaugural EH&S Information Management Award given out at the 2016 Verdantix Summit. One of only eight winners announced, Smith & Nephew won in the healthcare category for their development of an integrated safety and incident management system. Through its successful project for Smith & Nephew's Memphis location, Intelex Technologies, a global innovator of cloud-based environmental, health, safety, and quality (EHSQ) management software received a Verdantix EH&S Innovation Award.
SNN: 34.81 (+0.52)
Hip and Knee Orthopedic Surgical Implants - Global Market Outlook (2015-2022)
PR Newswire - Tue May 24, 4:32PM CDT
According to Stratistics MRC, the Global Hip and Knee Orthopedic Surgical Implants market is estimated at $18.26 billion in 2015 and is expected to grow at a CAGR of 9.54% to reach $34.57 billion by 2022. Technological advancements and rising geriatric population worldwide are some of the key factors fueling the market growth. On the other hand, abridged reimbursements by insurance companies are negatively affecting the market growth. Total hip replacement surgery is witnessing a significant rise driven by the technological advan. The aging US population is supporting the market demand, since the requirement of these medical devices is higher in the elderly population.
SNN: 34.81 (+0.52), JNJ: 122.92 (-0.01)
Medtronic to Expand Minimally Invasive Therapy Portfolio with Acquisition of Gynecology Business from Smith & Nephew
Globe Newswire - Wed May 18, 7:01AM CDT
DUBLIN - May 18, 2016 - Medtronic plc (NYSE: MDT) today announced it has signed a definitive agreement to acquire Smith & Nephew's (NYSE: SNN; LSE: SN) gynecology (GYN) business for approximately $350 million. This agreement reinforces Medtronic's dedication to expanding the use of less invasive treatments and demonstrates a commitment to improving options for women with abnormal uterine bleeding (AUB). The addition of the GYN portfolio will expand and strengthen Medtronic's minimally invasive surgical offerings and will further complement its existing global GYN business. The acquisition is expected to close this summer.
SNN: 34.81 (+0.52), MDT: 88.92 (+0.41)
Global Orthopaedic Device Company Profiles of The Top 5 - DePuy Synthes, Medtronic, Smith & Nephew, Stryker & Zimmer Biomet - Research and Markets
BusinessWire - Wed May 18, 6:50AM CDT
Research and Markets has announced the addition of the "Orthopaedic Device Company Profiles: The Top 5" company profile to their offering.
SNN: 34.81 (+0.52), MDT: 88.92 (+0.41)
Upgrade Alert for Smith & Nephew (SNN)
Comtex SmarTrend(R) - Tue May 10, 4:09AM CDT
Smith & Nephew (NYSE:SNN) was upgraded from Hold to Buy at Jefferies today. The stock closed yesterday at $34.04 on volume of 371,000 shares, above average daily volume of 302,000. There is potential upside of 17.1% for shares of Smith & Nephew based on a current price of $34.04 and an average consensus analyst price target of $39.88. The stock should hit resistance at its 200-day moving average (MA) of $34.17, as well as support at its 50-day MA of $33.33.
SNN: 34.81 (+0.52)
Laparoscopic Devices Market: Global Industry Analysis 2015-2025 - Key Players are Medtronic, Ethicon US LLC & Smith & Nephew - Research and Markets
BusinessWire - Mon Apr 18, 7:52AM CDT
Research and Markets has announced the addition of the "Laparoscopic Devices Market: Global Industry Analysis and Opportunity Assessment 2015-2025" report to their offering.
SNN: 34.81 (+0.52)
Smith & Nephew awarded Skin Integrity: Prevention, Healing and Support category agreement with Premier, Inc.
PR Newswire - Tue Apr 12, 7:00AM CDT
Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced that it has been awarded a group purchasing agreement for the Skin Integrity: Prevention, Healing and Support category with Premier, Inc. Effective April 1, 2016, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Smith & Nephew's Advanced Wound Care products, including the ALLEVYN(TM) family of hydrocellular foam dressings, SECURA(TM) skin care system and ACTICOAT(TM) silver-coated antimicrobial barrier dressings.
SNN: 34.81 (+0.52)
Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic and Smith & Nephew
Zacks Equity Research - Zacks Investment Research - Tue Mar 22, 8:30AM CDT
Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic and Smith & Nephew
SNN: 34.81 (+0.52), JNJ: 122.92 (-0.01), MDT: 88.92 (+0.41)
Medical Products Companies Tap Into $50 Billion U.S. Government GSA Supply Program
ACCESSWIRE - Wed Mar 16, 7:30AM CDT
REDONDO BEACH, CA / ACCESSWIRE / March 16, 2016 / Last week, BioLargo, Inc. (OTC: BLGO), best known for the AOS Filter that has demonstrated the highest impact and lowest cost of any known water treatment technology, announced that the U.S. government had awarded them a five-year General Services Administration and VA Schedule supply contract, under schedule 65IIA for medical equipment and supplies. This contract award is significant because it opens up an important selling channel for the company's current odor and moisture control products as well as future products that will include its Advanced Wound Care Products when they are approved by the FDA. The GSA Schedules program is the premier acquisition vehicle in government with approximately $50 Billion a year in spending for a broad spectrum of products.
DSCI: 4.13 (-0.06), SNN: 34.81 (+0.52), VCEL: 2.24 (-0.03), ALQA: 1.18 (-0.01)
New "see-and-treat" TRUCLEAR(TM) hysteroscope improves options for office hysteroscopy
PR Newswire - Wed Mar 09, 7:00AM CST
Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announced the launch of the TRUCLEAR 5C Hysteroscope Set for the combined diagnosis and removal of abnormalities within the uterine cavity. The ability to identify and remove intrauterine pathologies using a single scope is known as "see-and-treat" by surgeons and reduces the need for patients to schedule multiple visits.
SNN: 34.81 (+0.52)
Wound Closure & Advanced Wound Care Global Market Report 2016-2021 - Analysis, Trends, Technologies & Opportunities - Key Vendors: Integra Lifesciences Corp, Johnson & Johnson, Smith & Nephew
PR Newswire Europe - Tue Mar 08, 9:11AM CST
DUBLIN, March 8, 2016 /PRNewswire/ --
SNN: 34.81 (+0.52), JNJ: 122.92 (-0.01)
